Nashville Is Site of Thermo Fisher’s Latest Expansion
Thermo Fisher Scientific, Inc, plans to build a manufacturing facility in Nashville, TN, for production of single-use technologies (SUT) products.
Category: Company News
Company News
Latest
Company News
Latest
Promega Receives FDA Clearance for OncoMate MSI Dx Analysis System
The OncoMate MSI Dx Analysis System has been cleared by the FDA as an IVD medical device to determine MSI status in colorectal cancer tumors.
Company News
Latest
Thermo Fisher Scientific Expands Corporate Leadership Team
Alan Sachs, who has served as Thermo Fisher Scientific chief scientific officer (CSO) since 2016, will assume the newly established role of chief medical officer (CMO) and will be succeeded by Karen E. Nelson.
Quest Diagnostics Completes Acquisition of Mercy’s Outreach Laboratory Services Business
Quest Diagnostics and Mercy announced that Quest has completed its acquisition of the outreach laboratory services business of Mercy.
Read More
Castle Biosciences to Acquire Myriad MyPath Laboratory
Castle Biosciences’ acquisition of CLIA-certified Myriad MyPath Laboratory from Myriad Genetics will expand its suite of genomic tests for skin cancer.
Read More
PerkinElmer to Acquire IVD Company Immunodiagnostic Systems Holdings
The acquisition will enable PerkinElmer to combine its channel expertise and testing capabilities with IDS’s chemiluminescence products in endocrinology, autoimmunity, and infectious diseases.
Read More
PerkinElmer Signs Agreement to Acquire Nexcelom Bioscience
Nexcelom is a global provider of automated cell counting instruments, image cytometry workstations, assays, and a variety of cell reagents and consumables.
Read More
New England Biolabs to Acquire Fluorogenics Limited
“The acquisition of FGL enables NEB to combine our expertise in enzyme manufacturing and assay development with their expertise in lyophilization, providing a complete solution for our customers,” says Jim Ellard, CEO of New England Biolabs.
Read More
BD to Spin Off Diabetes Care Business
The spinoff is expected to be completed in the first half of calendar year 2022.
Read More
Myriad Genetics to Sell Vectra Testing Business to Labcorp
Myriad Genetics has entered into a definitive agreement to sell select operating assets and intellectual property, including the Vectra test, from Myriad Autoimmune’s business unit to Labcorp for $150 million in cash.
Read More
PixCell Medical Acquired by Soulbrain Holdings
South Korea-based Soulbrain Holdings has acquired all controlling PixCell shares, making Soulbrain the majority shareholder of PixCell Medical.
Read More
Insightful Science, Dotmatics to Form Cloud-First Scientific R&D Company
Insightful Science has entered into a transaction to acquire Dotmatics, a cloud-based scientific R&D data management platform.
Read More
Hologic to Acquire Molecular Diagnostic Company Mobidiag
Hologic has signed a definitive agreement to acquire Mobidiag, a privately held, commercial-stage Finnish-French developer of molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million.
Read More
DiaSorin to Acquire Luminex for $1.8B
Through the acquisition, DiaSorin will gain access to Luminex’s molecular diagnostics multiplexing technology and a portfolio that will strengthen its existing offering while expanding its presence in the United States.
Read More
Mayo Clinic, Thermo Fisher Scientific Collaborate to Benefit Patients
The Mayo Clinic and Thermo Fisher teams are working closely to identify candidate solutions for clinical validation and global commercialization as part of the collaboration.
Read More
OGT Pledges Partnership With Brand Refresh and Integration
The OGT brand refresh has been driven by a desire to fully integrate the company’s three well-known brands of genomics solutions—CytoCell FISH probes, CytoSure array and NGS products, and SureSeq NGS panels.
Read More
Roche Signs Definitive Merger Agreement with GenMark Diagnostics
“Acquiring GenMark Diagnostics will broaden our molecular diagnostics portfolio to include solutions that can provide lifesaving information quickly to patients and their healthcare providers in the fight against infectious diseases,” says Thomas Schinecker, CEO Roche Diagnostics.
Read More
Diaago, Mawi DNA Technologies Partner to Provide Customizable Solutions with iSwab
The companies’ goal is to improve laboratory workflow/automation for covid-19 testing, sample storage, and biobanking.
Read More